Subchondral edema is a buildup of fluid in the bone just beneath the cartilage surface of a joint. It shows up on MRI scans as a bright, hazy signal in the bone marrow, and it’s recognized as a significant source of joint pain. You’ll often see it called a “bone marrow lesion” or “bone marrow edema” on radiology reports, and it most commonly appears in the knee, hip, and ankle.
The “subchondral” part refers to the layer of bone sitting directly under your cartilage. This bone acts as a shock absorber for the joint, and when it becomes stressed, overloaded, or damaged, fluid accumulates in the tiny spaces within the bone marrow. That fluid increases pressure inside the bone, which is what drives the pain.
What It Feels Like
The hallmark symptom is pain that gets worse with weight-bearing activity and, somewhat distinctively, also bothers you at night. The pain typically centers on the affected side of the joint. In the knee, for example, it often localizes to the inner (medial) compartment.
The intensity can vary widely. Some people describe a vague, dull ache, while others experience severe, disabling pain that comes on suddenly. Tapping or pressing on the affected area often reproduces the discomfort. In more acute cases, the pain can be bad enough to limit walking or require crutches. The nighttime component is particularly frustrating for many people, since rest doesn’t fully relieve it the way you might expect with a typical musculoskeletal injury.
Common Causes
Subchondral edema isn’t a single disease. It’s a finding that can result from several different problems, and the cause matters because it shapes the treatment approach.
- Osteoarthritis: This is the most common association. Abnormal mechanical forces from worn cartilage, joint malalignment, or obesity create repetitive stress on the subchondral bone. The MRI signal likely represents tiny fractures in the bone’s internal scaffolding (trabecular microdamage) and the body’s inflammatory response to repair them. Bone marrow lesions in osteoarthritis can fluctuate in size over time and are closely tied to cartilage breakdown and worsening pain.
- Acute injury: A ligament tear, meniscal injury, or direct impact can bruise the bone beneath the cartilage. These traumatic bone marrow lesions often appear in predictable patterns depending on how the injury occurred.
- Stress fractures: Repetitive loading, common in runners and military personnel, can produce a fracture line within the subchondral bone surrounded by a halo of edema.
- Spontaneous osteonecrosis (SONK): A sudden loss of blood supply to a small area of subchondral bone, most often on the inner part of the knee. It typically presents as acute pain that worsens at night and frequently coexists with meniscal tears.
- Bone marrow edema syndrome: A diagnosis of exclusion where significant edema and pain appear without another identifiable cause. It’s considered self-limiting, meaning it eventually resolves on its own, though recovery can take months.
- Inflammatory arthritis: Conditions like rheumatoid arthritis can produce bone marrow edema as part of the joint inflammation process.
How It’s Detected on MRI
Subchondral edema is invisible on standard X-rays. MRI is the only imaging tool sensitive enough to detect it. On an MRI, the affected bone marrow appears as a poorly defined, hazy area that looks dark on one type of image (T1-weighted) and bright on another (T2-weighted or fluid-sensitive sequences). Radiologists use specialized fat-suppressed sequences to make the edema stand out more clearly against the normal fatty bone marrow.
The MRI pattern also helps distinguish subchondral edema from more serious conditions. Avascular necrosis, where bone tissue dies from lack of blood supply, has a characteristic “double line sign” on MRI: a bright area surrounded by a dark ring. Stress fractures show an irregular dark line within the bone representing the actual fracture, surrounded by the brighter edema signal. Tumors that infiltrate bone marrow appear as well-defined areas with distinct borders, unlike the fuzzy, ill-defined edges of typical subchondral edema. These differences are important because they point toward very different treatment paths.
Why It Matters for Joint Health
Subchondral edema isn’t just a pain generator. It’s increasingly recognized as a marker of joint damage that can predict how the joint will hold up over time. Research from the Multicenter Osteoarthritis Study found that areas of the knee with bone marrow lesions were roughly 4 times more likely to already have cartilage damage, and 6 to 7 times more likely to develop new cartilage loss compared to areas without lesions. On the outer (lateral) side of the knee, ongoing cartilage loss was nearly 12 times more likely in zones with bone marrow lesions.
This two-way relationship between bone and cartilage is key. Damaged cartilage transfers abnormal stress to the bone below it, triggering edema. The edema and microdamage in the bone then alter the mechanical environment for the cartilage above, accelerating its breakdown. Bone marrow lesions have also been shown to predict a higher risk of eventually needing a knee replacement in people with osteoarthritis.
Treatment Options
Treatment depends entirely on the underlying cause, but most cases start with conservative management. The first-line approach typically involves reducing the load on the affected joint through partial weight-bearing (often with crutches), rest, and anti-inflammatory medication. For traumatic bone marrow edema without a fracture, this approach usually leads to resolution within 2 to 4 months.
When subchondral edema is linked to osteoarthritis, medications that slow bone turnover have shown promise. Multiple randomized controlled trials have demonstrated that these drugs can meaningfully reduce both lesion size and pain. Physical therapy to improve joint alignment and muscle support is often part of the plan, since correcting how forces travel through the joint addresses one of the root causes.
For inflammatory conditions like rheumatoid arthritis, treatment focuses on controlling the underlying disease with anti-inflammatory and immune-modulating medications. For bone marrow edema syndrome, the condition is self-limiting but slow: partial weight-bearing, immobilization, and pain management form the baseline, with some centers adding shock wave therapy or IV medications to speed recovery.
When Surgery Comes Into Play
If conservative treatment fails after 2 to 6 months of moderate to severe pain, and MRI confirms a bone marrow lesion in the same compartment as the pain, a procedure called subchondroplasty may be considered. During this minimally invasive surgery, a bone substitute paste (made from calcium phosphate) is injected directly into the lesion to fill and stabilize the damaged area. The injected material typically ranges from 5 to 16 milliliters depending on the size of the lesion.
This procedure is generally offered to patients between 40 and 75 years old and is not appropriate for everyone. People with significant joint instability, severe malalignment, widespread arthritis affecting all three knee compartments, or autoimmune diseases are typically not candidates. The goal is to provide structural support to the weakened bone and reduce the pain that comes from the elevated pressure inside the lesion.
Recovery and What to Expect
The timeline for subchondral edema to resolve varies significantly by cause. Isolated traumatic cases often clear within 2 to 4 months with rest and offloading. Bone marrow edema syndrome can take considerably longer, sometimes 3 to 12 months, though symptoms usually improve well before the MRI normalizes. Edema linked to osteoarthritis tends to wax and wane, since the underlying mechanical problem persists.
One important point: the MRI findings often lag behind symptom improvement. You may feel substantially better while the scan still shows residual edema. Conversely, some people have bone marrow lesions on MRI with minimal symptoms. The clinical picture, meaning your pain and function, matters more than the image alone when tracking progress.